Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease

NCT07702396 is registered in ClinicalTrials.gov with Indus Hospital and Health Network as lead sponsor.

NCT NCT07702396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07702396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease
Lead sponsor
Indus Hospital and Health Network
Phase
Not applicable
Overall status
Completed
Start date
January 10, 2024
Completion date
September 20, 2024
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heptatitis c